CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02154425
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:57.736515+00:00
Published At: 2017-02-06T00:00:00+00:00
Record Updated At: 2018-04-03
Results Posted At: 2017-02-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Axial Spondyloarthritis (AxSpA)", "Non-radiographic Evidence-AxSpA", "Ankylosing Spondylitis", "Crohn\u0027s Disease", "Psoriatic Arthritis", "Rheumatoid Arthritis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-04-03"
protocolSection.identificationModule.nctId: "NCT02154425"
protocolSection.identificationModule.officialTitle: "A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia\u00ae (Certolizumab Pegol)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-02-06"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.